The company has developed a suite of functional genomic screening technologies, including a CRISPR-Cas9 platform. Horizon’s aim is to help its partners to identify, evaluate and validate targets ...

The CRISPR screening workflow can map the impact of thousands of genetic perturbations on the global transcriptome at single-cell resolution, thus effectively establishing a paradigm for next ...

"Our research interest is to identify these genes in order to better treat diseases." CRISPR screening methods can be used to systematically examine genes for their function in cells. "CRISPR is ...

Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation for cell line engineering, today announced the ...

Horizon Discovery Group plc (LSE: HZD) ("Horizon", "the Company", or "the Group"), a global leader in the application of gene editing and gene modulation for cell line engineering, today announced the ...